<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03016793</url>
  </required_header>
  <id_info>
    <org_study_id>Pura-28568</org_study_id>
    <nct_id>NCT03016793</nct_id>
  </id_info>
  <brief_title>Alveolar Cleft Grafting Using Two Different Alloplastic Grafts</brief_title>
  <official_title>Evaluation of Esthetic Satisfaction and Bone Augmentation Quality Using Purabone Added to β-tricalcium Phosphate Versus β-tricalcium Phosphate Alone in Secondry Alveolar Cleft Grafting . Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      P-patients with unilateral alveolar clefts I-purabone with -β-tricalcium phosphate graft
      C-β-tricalcium phosphate graft alone O-clinical out come Outcome name Measurement device
      Measurement unit Esthetic satisfaction (Primary outcome) Numerical rating scale(NRS) Number
      0—10

      Radiographic outcome:

      Outcome name Measurment Device Measurment unite Bone volume

      (Secondary out come) (CBCT)machine Cranex 3D Sordex Cubic millimeter Bone Density

      (Secondary Outcome) (CBCT)machine Cranex 3D Sordex Hounsfield Unite Research Question Would
      purabone addition to β-tricalcium phosphate be more effective and esthetically satisfying
      than tricalcium phosphate alone in alveolar cleft grafting?
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2017</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Esthetic satisfaction</measure>
    <time_frame>6 months</time_frame>
    <description>outcome measured by numerical scale from 1-10</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>bone volume</measure>
    <time_frame>6 months</time_frame>
    <description>outcome measured by cone beam computed tomography ( CBCT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>bone density</measure>
    <time_frame>6 months</time_frame>
    <description>Outcome measured by cone beam computed tomography (CBCT)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Alveolar Cleft Grafting</condition>
  <arm_group>
    <arm_group_label>puerarin and β- tricalcium phosphate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>purabone (puerarin) is an osteoinductive bone grafts used to augment bone healing.
β- tricalcium phosphate is an osteoconductive bone graft used to augment bone healing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>β- tricalcium phosphate alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>β- tricalcium phosphate is an osteoconductive bone graft used to augment bone healing</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Puerarin</intervention_name>
    <description>purabone (puerarin) is a bone graft used for surgical repair of bony defects.</description>
    <arm_group_label>puerarin and β- tricalcium phosphate</arm_group_label>
    <other_name>purabone</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>β- tricalcium phosphate</intervention_name>
    <description>β- tricalcium phosphate is a bone graft used for surgical repair of bony defects</description>
    <arm_group_label>puerarin and β- tricalcium phosphate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>β- tricalcium phosphate alone</intervention_name>
    <description>β- tricalcium phosphate is a bone graft used for surgical repair of bony defects</description>
    <arm_group_label>β- tricalcium phosphate alone</arm_group_label>
    <other_name>β- tricalcium phosphate</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients with unilateral alveolar cleft indicated for bone grafting.

          2. Patients age range between 8-12years.

        Exclusion Criteria:

          1. Patients with any systemic diseases that can affect normal bone and/or wound healing.

          2. Patients with bilateral alveolar clefts.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samar Swelam, Phd</last_name>
    <role>Study Director</role>
    <affiliation>faculty of oral and dental medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohamed H Maklad, BSC</last_name>
    <phone>+201002648553</phone>
    <email>dentomaklad@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mohamad hamed Maklad</name>
      <address>
        <city>Suez</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mohamd H Maklad, BSC</last_name>
      <phone>+201002648553</phone>
      <email>dentomaklad@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 23, 2016</study_first_submitted>
  <study_first_submitted_qc>January 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2017</study_first_posted>
  <last_update_submitted>January 9, 2017</last_update_submitted>
  <last_update_submitted_qc>January 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Mohamad Hamed Maklad</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Puerarin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

